Foveon

Advanced Equities Fined Over Failure to Disclose Material Information Concerning Fisker Automotive Private Placements (Part II)

July 29, 2014 | by Staff Attorney

As we recently posted, our firm has covered the failures concerning the sale and recommendation of Advanced Equities private placement since the SEC brought charges against the firm. We also represent numerous clients who have unfortunately invested in these products that were alleged to have been sold as “late-stage private equities” by First Allied Securities brokers among others.

Recently, FINRA fined Advanced Equities $250,000 concerning allegations that between approximately November 1, and December 1, 2011, AEI, failed to identify material information and correct omissions of material facts made by the issuer in connection with a private placement offering.

As a background, Fisker Auto was an American automobile maker that manufactured hybrid electric vehicles. Shares in the company were sold through limited liability companies to accredited investors. In or around September 2009, Fisker Auto obtained a “loan facility” in the approximate amount of $529 million, which was overseen by the United States Department of Energy (DOE). Under the terms of the loan facility agreement, Fisker Auto could seek reimbursement costs associated with the production of two cars if the company was in compliance with certain financial covenants and project milestones. Those covenants generally included milestones requiring that Fisker Auto to achieve a certain level of earnings, sell a particular number of automobiles, and complete certification requirements related to safety and environmental matters.

Advanced Equities Fined Over Allegations of Failure to Disclose Information Concerning Fisker Automotive Private Placements

July 25, 2014 | by Staff Attorney

Our firm has covered the supervisory and due diligence failures concerning the sale and recommendation of Advanced Equities private placement since the SEC brought charges against the firm and its principals for selling one of its products by making material misrepresentations to investors. We also represent numerous clients who have unfortunately invested in these products that were alleged to have been sold as “late-stage private equities” by First Allied Securities brokers among others. Below are posts with additional information concerning these products.

Gana LLP Files Claim Against First Allied Securities on Behalf of Luxtera Investors

June 2, 2014 | by Staff Attorney

The law offices of Gana Weinstein LLP filed a complaint with the Financial Industry Regulatory Authority (FINRA) on behalf of four investors against First Allied Securities, Inc. (First Allied) concerning broker Amram a/k/a Rami Yahalom’s solicitation and sale of Advanced Equities private placements. According to the complaint, First Allied and Yahalom sold the investors AE Luxtera Investments II, LLC (Luxtera), a private placement in a technology start-up company by misrepresenting Luxtera’s prospects and failing to conduct even basic due diligence on the company before recommending the investment to clients.

In the context of a Regulation D offering, FINRA requires broker-dealers to conduct a reasonable investigation of the issuer and the securities they recommend in offerings. The investors alleged that First Allied failed to meet FINRA’s due diligence requirements and made representations that were misleading. The investors alleged that Yahalom and First Allied marketed Luxtera and other private placements as “late stage equities” that were a mere 12-36 months from going public through an IPO. Luxtera was also allegedly sold to customers under the false premise that the company would provide “Higher near-term investment returns than the public equity markets” while providing “Greater short-term liquidity and lower risk profiles.”

However, according to the complaint, these representations were misleading and false. The complaint alleged that First Allied sought to raise $43 million for Luxtera based on a $175 million valuation that was 22 times Luxtera’s projected 2008 revenues. In addition, the investors alleged that while First Allied knew that Luxtera had only achieved $1 million in sales as of November 30, 2008, their broker provided them with a slide-show presentation that projected 2009 sales as high as $89,447,500 and 2010 sales could reach $341,883,000. The complaint alleged that First Allied lacked a good faith basis to believe that Luxtera would experience 8,945% sales growth in one year and 34,188% sales growth over the next two years when the company was then suffering losses in excess of $30 million a year.